International controversies over section 3 d of the Indian Patent Act
Activity: Talk or presentation types › Lecture and oral contribution
Timo Minssen - Lecturer
- Faculty of Law Research Centres
- Centre for Information and Innovation Law
This presentation will discuss the Indian Novartis litigation challenging the Constitutional validity and scope of the recently added Sec. 3(d) of the Indian Patents Act, 1970. An analysis of this dispute is very important since one of the issues brought forth is India's compliance with TRIPS. Further, this case raises crucial issues with regard to the patentability of formulation inventions, which is linked to the so-called “evergreening” debate.
A presentation given at a 5 days intensive training for practitioners/professionals in Pharma Law & Policy (CSU), 13 – 17 August 2012, 9, at the University of Copenhagen, Frederiksberg Campus.
A presentation given at a 5 days intensive training for practitioners/professionals in Pharma Law & Policy (CSU), 13 – 17 August 2012, 9, at the University of Copenhagen, Frederiksberg Campus.
16 Aug 2012
Event (Course)
Title | Pharmaceutical Law & Policy- Hot topics shaping the future of the pharma industry |
---|---|
Abbreviated title | CSU |
Date | 13/08/2012 → 17/08/2012 |
Location | University of Copenhagen, Frederiksberg Campus |
City | Copenhagen |
Country/Territory | Denmark |
ID: 40317409